Ublituximab

Records for this ingredient, by country (identity only).

ATC L04AG14 · 5 markets · 7 records

Ublituximab 5 markets · 7 records Forms

Filters

MarketAU 3 US 1 GB 1 ES 1 EU 1

Strength

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

150 mg/6 mLinjectionBRIUMVI also in US·GB
25 mg/mL per mL / per unit basis not statedinjectionBRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BRIUMVI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

150 mg/6 mLinjectionBRIUMVI also in AU·GB

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

150 mg/6 mLinjectionBriumvi 150mg/6ml concentrate for solution for infusion vials also in AU·US

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

150 mg per mL / per unit basis not statedinjectionBRIUMVI

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名BRIUMVI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	AU	ES	EU
150 mg/6 mL injection	BRIUMVI	Briumvi 150mg/6ml concentrate for solution for infusion vials	BRIUMVI	not recorded	not recorded
150 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	BRIUMVI	not recorded
25 mg/mL per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	BRIUMVI	not recorded	BRIUMVI

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.